Erectile Dysfunction Clinical Trial
Official title:
Titan® One Touch Release Inflatable Penile Prosthesis
The purpose of this study is to assess the ease of deflation of the Titan® OTR pump.
Status | Completed |
Enrollment | 124 |
Est. completion date | April 2010 |
Est. primary completion date | October 2009 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Participant has an estimated life expectancy of more than 5 years - Participant has been diagnosed with erectile dysfunction (impotence) - participant is willing to have the Titan OTR IPP implanted - Participant is able and willing to complete all follow-up visits and procedures indicated in the protocol Exclusion Criteria: - Participant is unable or unwilling to sign the Informed Consent Form and /or comply with all follow-up requirements according to the study protocol - Participant had a previous penile prosthesis or prior penile enlargement surgeries - Participant has a compromised immune system, such as systemic lupus erythematosus, discoid lupus, or scleroderma - Participant has had a myocardial infarction or coronary artery stent placement within 2 months prior to treatment - Participant currently has uncontrolled or severe diabetes or other disease significantly reducing wound healing ability - Participant does not have the manual dexterity or mental ability to operate the pump - Participant has chordee or priapism - Participant has penile sensory neuropathy - Participant has serious bleeding disorder |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | St Joseph's Hospital | London | Ontario |
United Kingdom | University College London Hospital | London | UK |
United States | Emory Healthcare | Altanta | Georgia |
United States | Michigan Urology Center | Ann Arbor | Michigan |
United States | Boston Medical Center | Boston | Massachusetts |
United States | Rush Presbyterian | Chicago | Illinois |
United States | Carolina Urologic Research Center | Myrtle Beach | South Carolina |
United States | Urology San Antonio | San Antonio | Texas |
Lead Sponsor | Collaborator |
---|---|
Coloplast A/S |
United States, Canada, United Kingdom,
Ohl DA, Brock G, Ralph D, Bogache W, Jones L, Munarriz R, Levine L, Ritenour C. Prospective evaluation of patient satisfaction, and surgeon and patient trainer assessment of the Coloplast titan one touch release three-piece inflatable penile prosthesis. J — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assess the Ease of Deflation of the Titan® OTR Pump | The study's primary endpoint was to demonstrate that at least 64% of subjects were mostly or completely satisfied with the ability to deflate the device at the 6-month follow-up. The study's primary objective was to assess the ease of deflation of the Titan® OTR pump via subject questionnaire at 6-month follow-up. Subjects were asked via questionnaire how satisfied they were with ease of deflation of their implant. Success criteria was a response of "satisfactory" or "somewhat satisfactory". Other possible responses were "neither satisfactory nor unsatisfactory", "somewhat unsatisfactory", and "very unsatisfactory". | 6 months | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 1 | Subject Satisfaction - overall function | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 1 | Subject Satisfaction - overall function | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 1 | Subject Satisfaction - overall function | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 2 | Subject Satisfaction - soft enough to conceal when deflated | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 2 | Subject Satisfaction - soft enough to conceal when deflated | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 2 | Subject Satisfaction - soft enough to conceal when deflated | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 3 | Subject Satisfaction - ease of locating the deflation touch pads | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 3 | Subject Satisfaction - ease of locating the deflation touch pads | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 3 | Subject Satisfaction - ease of locating the deflation touch pads | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 4 | Subject Satisfaction - ease of inflation | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 4 | Subject Satisfaction - ease of inflation | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 4 | Subject Satisfaction - ease of inflation | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 5 | Subject Satisfaction - ease of deflation | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 5 | Subject Satisfaction - ease of deflation | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 5 | Subject Satisfaction - ease of deflation | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 6 | Subject Satisfaction - hardness of erection when inflated | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 6 | Subject Satisfaction - hardness of erection when inflated | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 6 | Subject Satisfaction - hardness of erection when inflated | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 7 | Subject Satisfaction - width when inflated | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 7 | Subject Satisfaction - width when inflated | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 7 | Subject Satisfaction - width when inflated | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 8 | Subject Satisfaction - length when inflated | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 8 | Subject Satisfaction - length when inflated | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 8 | Subject Satisfaction - length when inflated | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 9 | Subject Satisfaction - would you recommend this penile implant device to men with the same erectile difficulty that you had? | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 9 | Subject Satisfaction - would you recommend this penile implant device to men with the same erectile difficulty that you had? | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 9 | Subject Satisfaction - would you recommend this penile implant device to men with the same erectile difficulty that you had? | 12 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 10 | Subject Satisfaction - if you had the decision to make again, would you undergo this penile implant procedure again? | 3 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 10 | Subject Satisfaction - if you had the decision to make again, would you undergo this penile implant procedure again? | 6 months post-surgery | No |
Secondary | Evaluate User Acceptance of Titan® OTR - Question 10 | Subject Satisfaction - if you had the decision to make again, would you undergo this penile implant procedure again? | 12 months post-surgery | No |
Secondary | Assess the Ease of Implant of the Titan® OTR Question 1 | Titan OTR pre-implant product preparation was straightforward/simple? | At implant | No |
Secondary | Assess the Ease of Implant of the Titan® OTR - Question 2 | Titan OTR pre-implant product preparation was easier than your usual pump of choice? | At implant | No |
Secondary | Assess the Ease of Implant of the Titan® OTR - Question 3 | The subject was easily able to accommodate the OTR pump? | At implant | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 1 | It was easy for the subject to find the inflation bulb? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 2 | It was easy for the subject to find the deflation touch pads? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 3 | It was easy for the subject to inflate the device? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 4 | It was easy for the subject to compress the deflation touch pads? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 5 | Subject training with OTR pump was easier than with previous pump? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 6 | The OTR pump was easy to use at 1st cycling? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 7 | The subject likes the OTR pump? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 8 | How easy was it for the subject to learn? | 6 weeks | No |
Secondary | Assess the Ease of Training for Titan® OTR - Question 9 | How likely the subject will need continued training or retraining? | 6 weeks | No |
Secondary | Assess Partner Satisfaction (Where Applicable) | The Partner Treatment Satisfaction Scale (TSS) was used. The TSS provides scores ranging from 0 to 100 in 5 domains of Ease of erection, Erectile function, Pleasure from sexual activity, Satisfaction with orgasm and Confidence to complete sexual activity with higher scores indicative of worse symptoms. Available data is summarized for each domain at each visit along with change from baseline. | Baseline | No |
Secondary | Assess Partner Satisfaction (Where Applicable) | The Partner Treatment Satisfaction Scale (TSS) was used. The TSS provides scores ranging from 0 to 100 in 5 domains of Ease of erection, Erectile function, Pleasure from sexual activity, Satisfaction with orgasm and Confidence to complete sexual activity with higher scores indicative of worse symptoms. Available data is summarized for each domain at each visit along with change from baseline. | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05366504 -
LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment
|
Phase 2/Phase 3 | |
Recruiting |
NCT02745808 -
Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes
|
Phase 1 | |
Recruiting |
NCT02573805 -
the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males
|
N/A | |
Withdrawn |
NCT02579148 -
Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes
|
Phase 1 | |
Withdrawn |
NCT01967251 -
Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction
|
Phase 2 | |
Recruiting |
NCT02225548 -
Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
|
Phase 4 | |
Completed |
NCT02587988 -
Trial to Evaluate the Efficacy and Safety of HCP1302
|
Phase 3 | |
Completed |
NCT02945462 -
Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)
|
Phase 1 | |
Completed |
NCT01937871 -
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
|
Phase 3 | |
Completed |
NCT01698684 -
Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction
|
Phase 4 | |
Not yet recruiting |
NCT01321489 -
A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
|
Phase 3 | |
Terminated |
NCT01262833 -
Pudendal Assessment in Erectile Dysfunction
|
N/A | |
Completed |
NCT02226237 -
Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy
|
N/A | |
Completed |
NCT01230541 -
Effect of Udenafil on Spermatogenesis
|
Phase 1 | |
Completed |
NCT01037218 -
Treatment of Erectile Dysfunction II
|
Phase 3 | |
Completed |
NCT01037244 -
Treatment of Erectile Dysfunction I
|
Phase 3 | |
Recruiting |
NCT00313898 -
Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males
|
Phase 4 | |
Completed |
NCT00667979 -
Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse
|
Phase 4 | |
Completed |
NCT00421083 -
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
|
Phase 3 | |
Completed |
NCT00663728 -
Assessment of Duration of Erection With Vardenafil 10 mg
|
Phase 4 |